Search

Your search keyword '"Rives, Lynette"' showing total 93 results

Search Constraints

Start Over You searched for: Author "Rives, Lynette" Remove constraint Author: "Rives, Lynette"
93 results on '"Rives, Lynette"'

Search Results

1. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder

2. Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly

3. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

4. Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities

5. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

7. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

8. De novo variants in DENND5B cause a neurodevelopmental disorder

9. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

10. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

11. Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care

12. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

13. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

14. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

15. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

16. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

17. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

18. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

19. De novo variants in DENND5B cause a neurodevelopmental disorder

20. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

21. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

22. Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mosaic CACNA1D variant.

23. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

24. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

25. Probable digenic inheritance of Diamond–Blackfan anemia.

26. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

27. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

28. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

29. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

30. A medical odyssey of a 72‐year‐old man with Charcot–Marie–Tooth disease type 2 newly diagnosed with biallelic variants in SORD gene causing sorbitol dehydrogenase deficiency.

31. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

32. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

33. Novel variant in CADM3 causes Charcot-Marie-Tooth disease.

34. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

35. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

36. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

37. One is the loneliest number: genotypic matchmaking using the electronic health record

38. Rare Variants in RTEL1 Are Associated with Familial Interstitial Pneumonia

39. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

40. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

41. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

42. Loss-of-function in RBBP5results in a syndromic neurodevelopmental disorder associated with microcephaly

43. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

44. Dominant missense variants in SREBF2are associated with complex dermatological, neurological, and skeletal abnormalities

45. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

46. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

47. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

48. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

49. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

50. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region

Catalog

Books, media, physical & digital resources